Bellicum Pharmaceuticals, Inc. (BLCM) Financials
BLCM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 6.9 million | 33.9 million |
2023-06-30 | 8.7 million | 30.6 million |
2023-03-31 | 17.3 million | 27.3 million |
2022-12-31 | 23.8 million | 21.8 million |
BLCM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.5 million | 116000 |
2023-06-30 | -8.0 million | 59000 |
2023-03-31 | -6.4 million | 559000 |
2022-12-31 | -6.9 million | 714000 |
BLCM Net Income
No data available :(
BLCM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 5.9 million | - | - |
2023-06-30 | 7.4 million | - | - |
2023-03-31 | 15.4 million | - | - |
2022-12-31 | 21.8 million | - | - |
BLCM Shares Outstanding
BLCM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 263000 | 1.5 million | - |
2023-06-30 | 1000 | 4.8 million | 2.3 million | - |
2023-03-31 | 5000 | 7.2 million | 1.4 million | - |
2022-12-31 | 7000 | 6.3 million | 1.5 million | - |
BLCM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.0 million | - |
2023-06-30 | - | - |
2023-03-31 | 8000 | - |
2022-12-31 | 500000 | - |
BLCM
Price: $0.07
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -0.13
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 39500
Ebitda: -21.5 millionMarket Capitalization: 778326